Elevatus Welath Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Sell |
985
-117
| -11% | -$47.4K | 0.13% | 78 |
|
|
2025
Q1 | $548K | Buy |
1,102
+1
| +0.1% | +$497 | 0.31% | 49 |
|
|
2024
Q4 | $573K | Hold |
1,101
| – | – | 0.2% | 51 |
|
|
2024
Q3 | $681K | Sell |
1,101
-116
| -10% | -$71.8K | 0.22% | 48 |
|
|
2024
Q2 | $673K | Buy |
1,217
+1
| +0.1% | +$553 | 0.25% | 63 |
|
|
2024
Q1 | $707K | Buy |
1,216
+30
| +3% | +$17.4K | 0.28% | 46 |
|
|
2023
Q4 | $629K | Buy |
1,186
+18
| +2% | +$9.55K | 0.29% | 46 |
|
|
2023
Q3 | $591K | Buy |
1,168
+53
| +5% | +$26.8K | 0.53% | 35 |
|
|
2023
Q2 | $582K | Buy |
+1,115
| New | +$582K | 0.4% | 33 |
|